These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23143392)

  • 1. 4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis.
    Muñoz SA; Aranda F; Allievi A; Orden AO; Perés Wingeyer S; Trobo R; Alvarez A; Eimon A; Barreira JC; Schneeberger E; Dal Pra F; Sarano J; Hofman J; Chamorro J; de Larrañaga G
    Clin Exp Med; 2014 Feb; 14(1):83-9. PubMed ID: 23143392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
    Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
    Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R; Liu Z; Chen Z; Li L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients.
    Wingeyer SD; Graffigna MN; Belli SH; Benetucci J; de Larrañaga GF
    Genet Test Mol Biomarkers; 2012 May; 16(5):372-5. PubMed ID: 22106856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Bae SC; Lee YH
    Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -675 4G/5G
    Anaya-Macias BU; De la Cruz-Mosso U; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla G; González-López L; Gámez-Nava JI; Pérez-Guerrero EE; Barrientos-Avalos SL; Muñoz-Valle JF
    Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus.
    Santos MJ; Carmona-Fernandes D; Caetano-Lopes J; Perpétuo IP; Vidal B; Capela S; Canas da Silva J; Fonseca JE
    Rheumatol Int; 2012 Aug; 32(8):2239-44. PubMed ID: 21544635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the PAI-1 4G/5G Gene Polymorphism and the Risk of Systemic Lupus Erythematosus/Lupus Nephritis.
    Li W; Mao S; Wu L; Shi W; Zhang J; Wang Z
    Crit Rev Eukaryot Gene Expr; 2019; 29(1):85-94. PubMed ID: 31002598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tumor necrosis factor-alpha gene polymorphisms with juvenile systemic lupus erythematosus nephritis in a cohort of egyptian patients.
    Farid TM; Abd El Baky AM; Khalefa ES; Talaat AA; Mohamed AA; Gheita TA; Abdel-Salam RF
    Iran J Kidney Dis; 2011 Nov; 5(6):392-7. PubMed ID: 22057071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
    Gong R; Liu Z; Li L
    Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor gene polymorphisms are associated with systemic lupus erythematosus susceptibility or lupus nephritis in Mexican patients.
    Ramírez-Bello J; Cadena-Sandoval D; Mendoza-Rincón JF; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Sierra-Martínez M; Jiménez-Morales S
    Immunol Res; 2018 Jun; 66(3):348-354. PubMed ID: 29611038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the -844 G>A, HindIII C>G, and 4G/5G
    Valdés-Alvarado E; Huerta M; Trujillo X; Valle Y; Padilla Gutiérrez JR; Mireles-Ramírez MA; Macías-Islas MA; Luz Margarita BR; Muñoz-Valle JF
    Dis Markers; 2019; 2019():9626289. PubMed ID: 31687051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between TNF-α Promoter -308 A/G Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Case-Control Study and Meta-Analysis.
    Yang ZC; Xu F; Tang M; Xiong X
    Scand J Immunol; 2017 Mar; 85(3):197-210. PubMed ID: 27943420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study.
    Yousef AA; Mohamed FY; Boraey NF; Akeel NE; Soliman AA; Waked NM; Hashem MIA; Shehata H; Fahmy DS; Ismael A; Ibrahim LM; Ibrahim MAM; Salem HF; Yousry SM; Osman SF; Fouad RA; Enan ET; Attia MA; Afify MR; Zeidan NMS; Nashat M
    J Inflamm Res; 2020; 13():1103-1111. PubMed ID: 33363394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
    Borisov EN; Krasnova TN; Samohodskaia LM; Ivanitskiĭ LV; Nikiforova NV; Mukhin NA
    Ter Arkh; 2014; 86(6):57-62. PubMed ID: 25095657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.